General: 07354 486 586   |   Fundraising: 07511 821 181   |   Support: 0800 046 9832  
CLN7 Research Program Update- Statement From Global Batten Disease Organisations

We believe it's important to work together with our global patient advocacy partners to share important research updates in a unified, timely, and factual manner. Our network of organizations has worked together on this statement to share with our families…

Read More
Dr Joanna Nightingale, BDFA Scientific Officer In New Role Of Head Of Scientific Affairs

The BDFA is very pleased to announce that Dr Joanna Nightingale, our part-time Scientific Officer, will take up a new expanded role from April. Joanna will take up the role of Head of Scientific Affairs, a full-time post which will…

Read More
CLN3 Update, Research Call 19th Jan 2023

New advance to the Theranexus and BBDF Batten-1 program for juvenileBatten disease (CLN3) Read the press release from Beyond Batten and Theranexus regarding Phase I/II trial data at the link below. https://beyondbatten.org/wp-content/uploads/2023/01/Theranexus_PR_Batten-1_Program_VDEF.pdf They are hosting a Quarterly Family Research call…

Read More
Save The Date! BDFA Family Conference 2023!

Following on from our successful family conference in September, we have set the date for our Family conference in 2023! We had some wonderful feedback from the conference, so we are working hard make 2023 even better. One big change…

Read More
Would You Like To Become A BDFA Peer Befriender? Could You Give Support To Another Family Living With Batten Disease?

Why not kick off 2023 with a new challenge to help support other Batten families! The course starts on Tuesday 24th January 2023, where you will have expert training and become a vital part of our wonderful Peer befriending volunteer…

Read More
An Important Official Update From REGENXBIO On Gene Therapy Developments For CLN2 Batten Disease

An important official update from REGENXBIO on gene therapy developments for CLN2 Batten disease, read the press release here or via the link. December 21, 2022 at 7:05 AM EST RGX-181 and RGX-381 are potential one-time AAV Therapeutics for the…

Read More
BDFA Family Conference In Stratford Upon Avon, Thank You!

Every emotion resonated at our family conference in Stratford Upon Avon last weekend, the first in five years. The joy of reunion, the power of connection, the comfort of camaraderie… it was such a special weekend with tears and laughter…

Read More
Exciting Update From Theranexus Regarding Clinical Trial In 2023 For CLN3

Exciting update from Theranexus regarding clinical trial in 2023 for CLN3 Please read the article below

Read More
Welcome To Dr Joanne Nightingale As Scientific Officer To The BDFA

We hope you will join us in wishing a warm welcome to Dr Joanne Nightingale as our new BDFA Scientific Officer. Jo has with a wealth of experience in scientific research and has worked in the lab doing pre-clinical research…

Read More
Update From Theranexus On A New Treatment For CLN3

Thanks to Theranexus for sharing this update, and also for being one of our gold sponsors at the BDFA family conference in September. Theranexus is committed to support patients with rare neurological disorders by focusing all its research efforts on…

Read More

Make a donation:

To make a donation please click the button to the right.  This link will then take you to a PayPal page where a donation direct to us can be made.

The amount you enter is your choice and PayPal can collect the funds from a debit or credit card account.

Thank you for your donation.